Compare Supplements

284 mg (300 mg inclisiran sodium) by subcutaneous injection administered by a healthcare professional on day 1, again at day 90 (month 3), then every 6 months thereafter. A prescription drug; this is the approved regimen, not a self-directed supplement protocol.

Any time

Prefilled subcutaneous injection (inclisiran 284 mg)

5–20 mg once daily (up to 40 mg in selected high-risk patients), titrated to LDL/ApoB targets — under a clinician. A prescription drug; not a self-directed supplement regimen.

Any time

Oral tablet (rosuvastatin 5–20 mg)

• Known hypersensitivity to inclisiran or excipients
• Not a substitute for a clinician's evaluation — prescription drug only

• Statins / ezetimibe
• PCSK9 monoclonal antibodies (evolocumab / alirocumab)

• Active liver disease or unexplained persistent transaminase elevations
• Pregnancy and breastfeeding
• Known hypersensitivity to rosuvastatin

• Cyclosporine
• Gemfibrozil
• Certain antivirals / protease inhibitors